Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
32.96
+0.12 (0.37%)
Aug 18, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Denmark Revenue
-3.33B2.87B
Netherlands Revenue
-1.00M-
United States Revenue
-180.00M131.00M
Japan Revenue
-213.00M122.00M
Revenue (Total)
4.13B3.72B3.12B

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
DARZALEX Royalties Revenue
2.66B2.44B2.02B
Kesimpta Royalties Revenue
504.00M443.00M323.00M
TEPEZZA Royalties Revenue
117.00M105.00M106.00M
Other Product Royalties Revenue
150.00M111.00M69.00M
Total Royalties Revenue
3.43B3.10B2.52B
Net Product Sales
483.00M398.00M253.00M
Reimbursement Revenue
37.00M53.00M144.00M
Milestone Revenue
110.00M97.00M145.00M
Collaboration Revenue
69.00M70.00M62.00M
Revenue (Other)
-3.43B-3.10B-2.52B
Revenue (Total)
4.13B3.72B3.12B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
J&J Revenue
2.80B2.57B2.09B
Roche Revenue
117.00M106.00M107.00M
Novartis Revenue
507.00M446.00M408.00M
BioNTech Revenue
14.00M40.00M127.00M
Pfizer Revenue
75.00M77.00M77.00M
AbbVie Revenue
-66.00M58.00M
Other Collaboration Partner Revenue
-22.00M-
Total Other Collaboration Partner Revenue
132.00M88.00M58.00M
Revenue (Total)
4.13B3.72B3.12B